145
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Post-Biopsy Rise in Serum PSA : A Potential Tool for the Dynamic Evaluation of Prostate Cancer/Prostatic Intraepithelial Neoplasia (PIN)

Pages 68-71 | Published online: 01 Jan 2003
 

Abstract

Objectives. The biochemical response of prostatic cells to needle core biopsies is known to manifest as a rise in serum PSA. The aim of this study is to evaluate the PSA response to mechanical trauma in prostate cancer patients, when compared to benign controls.

Materials and Methods. 50 consecutive patients undergoing transrectal ultrasound guided prostatic needle biopsies had their total serum PSA measured thirty minutes after the procedure. Change from the baseline PSA was estimated and correlated to histology.

Results. Data was analysed in 48 patients (mean age 68 years; range 55-87 years). Histology showed benign, cancer and PIN results in 24, 19 and 5 patients respectively. The highest rise in post biopsy PSA was observed in the PIN group. A significant difference in the rise in serum PSA was noted between controls and the cancer group. Conclusion. Post biopsy PSA response differs significantly between benign and malignant prostatic tissue. PIN causes an excessive rise in PSA values on mechanical stimulation. This small study indicates that the biopsy model may help us to assess the dynamics of prostate cancer.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.